APRN CORNER INFORMATION

APRN's with prescriptive authority may prescribe medications that have an FDA approved indication for weight management (i.e. management of obesity) that are NOT controlled substances. Contrave is not categorized as a controlled substance at this time, therefore APRN's are not prohibited by current rules from prescribing this agent.   This information was published in the APRN Corner of The Examiner Vol 24, No. 1.

Other information included in the APRN Corner include:

Prescribing of Zolpidem:  Label changed delineated new dosing regimens including lower initial dosing of immediate release formulations for women (5 mg).  The Warnings and Precautions section of the label also includes a warning that patients taking the extended release formuations should not drive or participate in other activiteis that require full alertness the day after taking the sleep aid.

APRN Specialty Practices and Titles:  If APRN's elect to include a specific population in their title, they must ensure that the credentials and title utilized are appropriate, authorized, and accurately reflect the role and population focus within which they are licensed. APRN's who hold additional national certification from a certifying agency accredited by the NCCA or the ABSNC may also utilize the credentials authorized by the certifying agency.  If so they must also utilize a title that reflects the role and population focus within which they are licensed.